These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24050506)

  • 21. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
    Tsimberidou AM; Catovsky D; Schlette E; O'Brien S; Wierda WG; Kantarjian H; Garcia-Manero G; Wen S; Do KA; Lerner S; Keating MJ
    Cancer; 2006 Jul; 107(1):125-35. PubMed ID: 16700034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
    Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
    Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Splenic marginal zone lymphoma].
    Mohamed S
    Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma.
    Milosevic R; Todorovic M; Balint B; Jevtic M; Krstic M; Ristanovic E; Antonijevic N; Pavlovic M; Perunicic M; Petrovic M; Mihaljevic B
    World J Gastroenterol; 2009 Aug; 15(32):4009-15. PubMed ID: 19705496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base.
    Fallah J; Olszewski AJ
    Hematology; 2019 Dec; 24(1):378-386. PubMed ID: 30885066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-tailored treatment of splenic marginal zone lymphoma.
    Castelli R; Balzarotti M; Salvi E; Simona Rossi R; Lambertenghi Deliliers G; Bergamaschini L; Gidaro A
    Anticancer Drugs; 2022 Jan; 33(1):e36-e42. PubMed ID: 34407041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes.
    Iannitto E; Minardi V; Calvaruso G; Ammatuna E; Florena AM; Mulè A; Tripodo C; Quintini G; Abbadessa V
    Eur J Haematol; 2005 Aug; 75(2):130-5. PubMed ID: 16000129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical management of splenic marginal zone lymphoma.
    Kennedy ND; Lê GN; Kelly ME; Harding T; Fadalla K; Winter DC
    Ir J Med Sci; 2018 May; 187(2):343-347. PubMed ID: 29043543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
    Else M; Marín-Niebla A; de la Cruz F; Batty P; Ríos E; Dearden CE; Catovsky D; Matutes E
    Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
    Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
    Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
    Thieblemont C; Felman P; Berger F; Dumontet C; Arnaud P; Hequet O; Arcache J; Callet-Bauchu E; Salles G; Coiffier B
    Clin Lymphoma; 2002 Jun; 3(1):41-7. PubMed ID: 12141954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of Upfront Therapy for Marginal Zone Lymphoma.
    Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time Trend Analysis of Splenectomy for Splenic Marginal Zone Lymphoma: Declining Surgery, Promising Survival.
    Yang Z; Liu L; Leng K; Shi G
    Ann Surg Oncol; 2023 Nov; 30(12):7206-7216. PubMed ID: 37516724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
    Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
    Sima A; Hollander P; Baecklund E; Smedby KE; Enblad G; Amini RM
    Br J Haematol; 2021 Aug; 194(3):568-579. PubMed ID: 34109612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases.
    Cervetti G; Ghio F; Cecconi N; Morganti R; Galimberti S; Petrini M
    J Chemother; 2017 Apr; 29(2):126-129. PubMed ID: 27454143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic marginal zone lymphoma: a case report and literature review.
    Zhang S; Xuan Z; Zhang L; Lu J; Song P; Zheng S
    World J Surg Oncol; 2020 Oct; 18(1):259. PubMed ID: 33004051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab monotherapy for splenic marginal zone lymphoma with villous lymphocytes: report on long-term disease control for two patients with recurrence after splenectomy.
    Debiasi M; Hehnemann M; Garicochea B
    Sao Paulo Med J; 2010 Dec; 128(6):375-7. PubMed ID: 21308163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas.
    Castelli R; Bergamaschini L; Deliliers GL
    Med Oncol; 2017 Dec; 35(2):15. PubMed ID: 29288421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.